Skip to main content
OpenTrials

Clinical trial condition

Anal Cancer

Explore clinical trials studying Anal Cancer. Study availability and eligibility vary by location and protocol.

125 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Anal Cancer trial results

Completed

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

NCT01946139

Conditions
Anal Cancer, Anus Diseases, Anus Neoplasms, +33 more
Locations
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • Ucsf Ancre San Francisco, California, United States
  • John H. Stroger Hospital of Cook County Chicago, Illinois, United States
  • Boston University Cancer Research Center Boston, Massachusetts, United States
View Trial Details
Completed

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

NCT00316888

Conditions
Anal Canal Carcinoma, Anal Cancer, Anus Diseases, +12 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
View all 125 locations
View Trial Details
Completed

Pembrolizumab in Metastatic Anal Cancer

NCT02919969

Conditions
Anal Cancer, Anus Diseases, Anus Neoplasms, +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Completed

Programs To Support You During Chemotherapy

NCT02489422

Conditions
Anal Cancer, Anus Diseases, Anus Neoplasms, +55 more
Locations
  • Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions